The domestic stock market has been Volatile this year, with key domestic equity indices–Sensex and Nifty–declining over 12 and 10 per cent, respectively. Going forward, the market movement could remain cautious, given the prevailing situation in the Middle East. Meanwhile, domestic brokerages and institutional research firms highlighted 'Buy' recommendations for holding periods ranging from a month to a year.  Brokerages including Choice Equity Broking, Choice Institutional Equities, and Geojit Investment Limited picked four stocks across sectors, projecting strong upside potential. The stocks that got a ‘Buy’ call are  Phoenix Mills Ltd, Action Construction Equipment Limited, Sun Pharmaceuticals, and Unimech Aerospace and Engineering. 

Stock To Invest 2026: Target Price And Potential Gains

Short-Term Recommendations (1 to 6 Months)

1. Phoenix Mills Ltd. (PHOENIXLTD)

  • Brokerage: Choice Equity Broking

  • Duration / Horizon: 1 Month

  • Current Price: Rs 1,921.40

  • Target Price: Rs 2,134

  • Stop Loss: Rs 1,815

Choice Equity Broking said that Phoenix Mills Ltd. is showing technical signals of a positive reversal on its daily price chart after experiencing a temporary retracement from recent highs. The stock has established solid support around the 0.618 Fibonacci retracement zone and is now witnessing renewed buying momentum.

Choice Equity Broking recommends a tactical short-term Buy over 1 month with a defined target of Rs 2,134.

2. Action Construction Equipment Limited (ACE)

  • Brokerage: Geojit Investment Limited

  • Category: Small Cap

  • Duration / Horizon: 3 - 6 Months

  • Current Price: Rs 1,299 (Recommended Entry Range: Rs 1,200 - Rs 1,260)

  • Target Price: Rs 1,600

  • Expected Return: 30%

Action Construction Equipment Ltd. (ACE) is a leading Indian construction equipment manufacturer featuring a highly diversified product portfolio across material handling, cranes, construction, and agricultural machinery, the brokerage noted.  

ACE holds a dominant market position in India, capturing over 63% market share in mobile/pick-and-carry cranes and approximately 60% in tower cranes.

Geojit said that ACE is well-positioned to deliver strong operational growth over the next 3 to 6 months, offering a projected upside of 30 per cent.

Long-Term Recommendations (12 Months and Beyond)

3. Sun Pharmaceutical Industries Limited

  • Brokerage: Geojit Investment Limited

  • Duration / Horizon: 12 Months

  • Current Market Price: Rs 1,836

  • Target Price: Rs 2,070

  • Expected Return: 13 per cent

Sun Pharmaceutical Industries Limited is India’s largest pharmaceutical firm and a global leader in speciality generic formulations and active pharmaceutical ingredients (APIs).

Geojit highlighted that in Q1FY27, Sun Pharma reported a robust 10.5 per cent YoY growth in consolidated revenue from operations, reaching Rs 15,300 crore. 

This growth, according to brokerage,  was primarily driven by strong domestic formulation sales and continued traction across its global Innovative Medicines portfolio.

Geojit maintains a 12-month target price of Rs 2,070, expecting high single-digit revenue growth spearheaded by speciality product launches and domestic market expansion.

4. Unimech Aerospace & Manufacturing

  • Brokerage: Choice Institutional Equities

  • Duration / Horizon: Multi-Year Cycle (Long-Term)

  • Current Price: Rs 1,591

  • Target Price: Rs 1,950

  • Expected Return: 22.5 per cent

Unimech Aerospace & Manufacturing is strategically aligned to capitalise on an extended, multi-year aerotooling cycle within global aviation. 

According to Choice Institutional Equities, key structural drivers include accelerating global commercial aircraft production rates, next-generation engine manufacturing programs, and steady recurring Maintenance, Repair, and Overhaul (MRO) demand.

Choice Institutional Equities projects an expected return of 22.5 per cent to a target of Rs 1,950, backed by strong long-term industry order visibility and specialised precision engineering capabilities.

Disclaimer: This story is for informational purposes only. It should not be considered as investment advice. All 'Buy' recommendations are the brokerage's call.  Please seek expert advice before investing.